A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox.
Investment firms of ultra-wealthy families stepped up their deal-making in April after a slowdown the month prior triggered by the outbreak of the Iran war.
Family offices made 55 direct investments in companies last month, up from 39 in March according to data provided exclusively to CNBC by Fintrx, a private wealth intelligence platform.
Nearly a third of April’s investments were made in healthcare and life sciences companies.
Laurene Powell Jobs’ Emerson Collective, her investment and philanthropy firm, joined fundraises for two startups, a seed round for Ultralight and a Series A round for Stipple Bio. Ultralight, an artificial intelligence software platform for personalized healthcare, raised $9.3 million in seed funding from Emerson Collective and other investors. Stipple Bio, a developer of targeted cancer therapies, raised $100 million in the round, which was co-led by Andreessen Horowitz.
